511-01-3 Usage
Uses
Used in Pharmaceutical Industry:
Alpha-onocerin is used as a potential therapeutic agent for its anti-inflammatory properties, aiming to alleviate various inflammatory conditions. Its ability to reduce inflammation could contribute to the development of new treatments for a range of diseases characterized by inflammation.
Used in Oncology:
In the field of oncology, alpha-onocerin is used as a potential anti-cancer agent, particularly in inhibiting the growth of cancer cells in breast and lung cancer models. Its mechanism of action in these contexts is under investigation, but its potential to impact cancer cell proliferation and survival makes it a promising candidate for further research and development in cancer therapies.
Further research is essential to fully understand the benefits and mechanisms of action of alpha-onocerin, which could lead to its integration into novel drug delivery systems or other therapeutic strategies to enhance its efficacy and bioavailability in clinical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 511-01-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,1 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 511-01:
(5*5)+(4*1)+(3*1)+(2*0)+(1*1)=33
33 % 10 = 3
So 511-01-3 is a valid CAS Registry Number.
511-01-3Relevant academic research and scientific papers
Mi, Yuan,Schreiber, Juerg V.,Corey
, p. 11290 - 11291 (2002)
A remarkably short (four steps, 31% overall yield) enantioselective synthesis of the structurally unique C2-symmetric tetracyclic triterpene (+)-α-onocerin (1) has been developed. The brevity of this mechanism depends on the assembly of four fragments (two molecules of a chiral epoxy ketone and two molecules of vinyllithium) to generate the chiral bis-epoxide 4 in one step, and on the efficient formation of all four carbocyclic rings in one step by cation-olefin tetracyclization. New and general methodology for the conversion of vinyl tert-butyldimethylsilyl ethers to vinyl triflates with retention of E or Z olefinic geometry also was utilized in the synthesis of 1. A short enantioselective synthesis of a non-C2-symmetric diastereomer of 1 is also described which uses the new methodology. Copyright
